Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

BACKGROUND: Inflammatory mediators, including acute phase reactants and cytokines, have been reported to be associated with clinical efficacy in patients with melanoma and other cancers receiving immune checkpoint inhibitors (ICI). Analyses of patient sera from three large phase II/III randomized IC...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Laino, Andressa S, Woods, David, Vassallo, Melinda, Qian, Xiaozhong, Tang, Hao, Wind-Rotolo, Megan, Weber, Jeffrey
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2020
Subjects:
Clinical/Translational Cancer Immunotherapy
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312339/
https://ncbi.nlm.nih.gov/pubmed/32581042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000842
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items